RNA-seq analysis showed that the transcriptional signature of the U2OS osteosarcoma cell line is altered by the overexpression of TRIB2 and exposure to the PI3K/mTOR inhibitor BEZ235. The gene discussed is TRIB2; the disease is osteosarcoma.